FDA silent on covid-19 vaccine safety signals
My latest investigation for The BMJ reveals that, in July 2021, the US Food and Drug Administration (FDA) quietly disclosed findings of a potential increase in four types of serious adverse events in elderly people who had had Pfizer’s covid-19 vaccine:
acute myocardial infarction,
disseminated intravascular coagulation,
immune thrombocytopenia, and
pulmonary embolism.
More than one year later, however, the agency has not issued a press release, or notified doctors, or published the findings via preprint or the scientific literature or updated the vaccines’ product label.
I spoke with leading doctors about the FDA’s failure to inform the public of these vaccine safety signals, and the consequences of keeping such information secret.
Here is a FREE LINK to the article and a link to the PDF
For paid subscribers, I am sharing an extended interview of my conversation with Tracy Høeg, epidemiologist and physician, currently doing covid-19 vaccine research with the Florida Department of Health and California’s Marin County Department of Health and Human Services.